Biotene

DEVICE4 trials

Sponsors

Unither Pharmaceuticals, France, Medical College of Wisconsin, University of Rochester, SunBio, Inc.

Conditions

Dry MouthHead and Neck CancerHyposalivationOral MucositisSjögren SyndromeXerostomia

Phase 3

Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy

TerminatedNCT02539342

Medical College of WisconsinOral Mucositis

Start: 2016-10-31End: 2017-03-02Updated: 2020-03-09

Phase 4

A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study

CompletedNCT02049112

Unither Pharmaceuticals, FranceHead and Neck Cancer, Hyposalivation, Sjögren Syndrome +1

Start: 2012-01-31End: 2013-06-30Updated: 2014-01-29

Unknown Phase

Duration of Effect of Biotene Spray in Patients With Dry Mouth

CompletedNCT03663231

University of RochesterDry Mouth

Start: 2019-02-11End: 2019-11-22Updated: 2021-01-20

Clinical Evaluation of MucoPEG™ for Xerostomia

CompletedNCT04986501

SunBio, Inc.Dry Mouth, Xerostomia

Start: 2022-05-02End: 2022-11-15Updated: 2025-05-23

Related Papers

Duration of effect of Biotène spray in patients with symptomatic dry mouth: A pilot study.

2021-01-168 citations